Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/2007
03/08/2007WO2007025385A1 Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with sod1 abnormalities
03/08/2007WO2007025366A1 Use of histogranin and histogranin-like compounds as inhibitors of p2x7 receptor function and as anti-arthritic agents
03/08/2007WO2007025347A1 Prophylactic and therapeutic agents and uses therefor
03/08/2007WO2007009691A3 Combination of substituted pyrazolines and anti -addictive agent
03/08/2007WO2007009395A8 Schisandrin b preparation
03/08/2007WO2007009044A3 Inhibitors of egln3 activity for the treatment of neurodegenerative disorders
03/08/2007WO2007008317A3 Process for preparation of sertraline hydrochloride form i
03/08/2007WO2006120575A3 Tcr-independent activation of t cells with co-lignation of cd28 and cd81
03/08/2007WO2006105455A3 Methods of treatment utilizing certain melatonin derivatives
03/08/2007WO2006103401A3 N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use
03/08/2007WO2006090289A8 Compounds for reducing aggregation of amyloid beta-peptide
03/08/2007WO2006027579A3 The treatment of inflammatory disorders and pain
03/08/2007WO2006004880A3 Substituted n-arylsulfonylheterocyclic amines as gamma-secretase inhibitors
03/08/2007WO2005115547A3 Myricitrin compounds for sleeping disorders
03/08/2007WO2003020702A3 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
03/08/2007US20070054962 Method for treating acute or chronic pain
03/08/2007US20070054961 Factor
03/08/2007US20070054950 3-Azabicyclo[3.1.0]hexane derivatives
03/08/2007US20070054940 Remedy for down's syndrome
03/08/2007US20070054931 Preparation of benzoylalkyl-1,2,3,6-tetrahydropyridines and use thereof
03/08/2007US20070054918 N-[(piperazinyl)hetary]arylsulfonamide compounds with affinity for the dopamine d3 receptor
03/08/2007US20070054913 4-(2-Butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
03/08/2007US20070054910 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
03/08/2007US20070054904 Phenol derivatives and their use as rotamase inhibitors
03/08/2007US20070054902 Isoxazole derivatives as peroxisome proliferator-activated receptors agonists
03/08/2007US20070054900 4-Phenlthiazole and 4-phenylimidizole derivatives and their use as medicaments for the treatment of neurodegenerative diseases, pain and epilepsy
03/08/2007US20070054886 Ras antagonists for treating neurodegenerative disorders
03/08/2007US20070054881 Anxiolytic agents with reduced sedative and ataxic effects
03/08/2007US20070054861 Therapeutic uses of SMR1 peptides
03/08/2007US20070054848 Composition and method for nerve regeneration
03/08/2007US20070054328 Methods
03/08/2007US20070054312 Human transmembrane proteins
03/08/2007US20070053992 Inhalable gaseous medicament based on xenon and nitrous oxide
03/08/2007US20070053982 Sustained release oral formulations
03/08/2007US20070053980 Extended release tiagabine formulations with reduced side-effects
03/08/2007US20070053964 Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist
03/08/2007US20070053926 Antigenic neisserial peptides
03/08/2007US20070053887 Method for production of neuroblasts
03/08/2007US20070053884 Novel adult tissue-derived stem cell and use thereof
03/08/2007DE102005037298A1 Use of four active electrolytes such as potassium, magnesium, calcium and zinc, as medicinal or food supplements for the treatment of Alzheimer's disease including other dementias
03/08/2007CA2625940A1 Use of histogranin and histogranin-like compounds as inhibitors of p2x7 receptor function and as anti-arthritic agents
03/08/2007CA2621162A1 Novel azabicyclo[3.2.1]oct-2-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
03/08/2007CA2620809A1 Prophylactic and therapeutic agents and uses therefor
03/08/2007CA2620742A1 Thiomorpholine compound and process for preparing the same
03/08/2007CA2620688A1 Heterocyclic compound
03/08/2007CA2620658A1 Novel indole compounds
03/08/2007CA2620351A1 Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with sod1 abnormalities
03/08/2007CA2619566A1 6-substituted-2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
03/08/2007CA2619450A1 6-n-linked heterocycle-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
03/08/2007CA2619287A1 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
03/08/2007CA2616797A1 Benzodiazepine derivatives , their preparation and the therapeutic use thereof
03/08/2007CA2616479A1 Treatment of optic neuritis
03/08/2007CA2616473A1 4-aryloxy quinoline derivatives as 5-ht6 modulators
03/08/2007CA2614232A1 Pyrazolo [3,4-d] azepine derivatives as histamine h3 antagonists
03/07/2007EP1760087A1 Novel protein complex and use thereof
03/07/2007EP1759701A2 Buproprion Metabolites and Methods of Their Synthesis and Use.
03/07/2007EP1758915A2 Composition and method for inhibiting platelet aggregation
03/07/2007EP1758907A1 Diphenylimidazopyrimidine and -imidazole amines as inhibitors of b-secretase
03/07/2007EP1758903A1 Pyrrolopyramidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists
03/07/2007EP1758898A1 Indolylalkylamine metabolites as 5-hydroxytrytamine-6 ligands
03/07/2007EP1758891A2 Benzimidazolone carboxylic acid derivatives
03/07/2007EP1758890A1 7-pyrazolylbenzazepines having affinity for d3 receptor
03/07/2007EP1758888A1 Butyrylcholinesterase selective inhibitors
03/07/2007EP1758884A2 N-cyclic sulfonamido inhibitors of gamma secretase
03/07/2007EP1758862A1 Aminopyridine derivatives as selective dopamine d3 agonists
03/07/2007EP1758860A1 Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in the treatment of pains, depressions and anxiety states
03/07/2007EP1758854A1 Pyrrolidin-3-yl compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
03/07/2007EP1758852A2 Substituted cyclopentene compounds
03/07/2007EP1758600A1 Methods and compositions for treating mood disorder
03/07/2007EP1758596A2 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
03/07/2007EP1704149B1 Triaza-cyclopenta[cd]indene derivatives
03/07/2007EP1513842B1 Substituted hexahydropyrrolo (1,2-a)pyrazines, octahydropyrido(1,2-a)pyrazines and decahydropyrazino(1,2-a)azepines
03/07/2007EP1450780B1 Use of 4-oxobutanoic acid derivatives in the treatment of inflammation
03/07/2007EP1442025B1 Pyrimidinones as melanin concentrating hormone receptor 1
03/07/2007EP1427411B1 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo [3.1.0] hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor
03/07/2007EP1372651B1 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity
03/07/2007EP1368304B1 Prodrugs of excitatory amino acids
03/07/2007EP1352061B9 Method for inhibiting the expression of a target gene
03/07/2007EP1333840B1 M. tuberculosis chaperonin 60.1 and uses thereof
03/07/2007EP1223808B1 Peripheral cannabinoid receptor (cb2) selective ligands
03/07/2007EP1043998B1 USE OF PYRAZOLO [3,4-b] PYRIDINE AS CYCLIN DEPENDANT KINASE INHIBITORS
03/07/2007EP1003784B1 Novel peptides and polypeptides useful for regenerating the nervous system
03/07/2007EP1001970B1 Dipeptide derivatives as growth hormone secretagogues
03/07/2007EP0959076B1 Heteroarylperidines and piperazines and their use as antipsychotics and analgetics
03/07/2007CN1926122A Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
03/07/2007CN1926117A 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power
03/07/2007CN1926114A Processes for preparing substituted N-aryl-N'-[3-(1H-pyrazol-5-yl) phenyl] ureas and intermediates thereof
03/07/2007CN1926109A Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
03/07/2007CN1926106A Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
03/07/2007CN1926105A Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
03/07/2007CN1926098A Novel urea derivatives and their medical use
03/07/2007CN1925861A Composition containing benzamidine derivative and method for stabilizing benzamidine derivative
03/07/2007CN1925859A 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as GABA receptor ligands for the treatment of anxiety, depression and epilepsy
03/07/2007CN1925850A Combination of the analeptic modafinil and an antidepressant for the treatment of depression
03/07/2007CN1925849A Pharmaceutical composition for inhibiting cognition hypofunction
03/07/2007CN1925844A Crystalline composition containing escitalopram oxalate
03/07/2007CN1924006A Anti-glioma peptide of scorpion, preparation method and application thereof
03/07/2007CN1923820A Novel carboxylic acid derivatives, their preparation and use
03/07/2007CN1923812A New compounds
03/07/2007CN1923803A Arginine rosmarinate, preparation method, pharmaceutical composition and use thereof
1 ... 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 ... 1833